Sign InBreakout Stocks of Week 23 @ PAR
NASDAQ was up last week (week 22) by 2.40% ending at 26,976.35 points after gaining 632.38 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Ipsen S.A. PAR:IPN. This stock has had a buy signal since May 29, 2026 when the price was 156.60€ , but have so far fallen 0% to 156.60€. Some other companies are on our watchlist to, among these are Technip Energies N.v. PAR:TE COFACE SA PAR:COFA Dassault Systèmes SE PAR:DSY and L'Air Liquide S.A. PAR:AI which all got a breakout pattern emerging.
| Date | Company | Price | Week 23 |
|---|---|---|---|
| Ipsen S.a. | 156.60€ | 157.80€ | 0.766% |
| Technip Energies N.v. | 35.46€ | 35.00€ | -1.30% |
| Coface Sa | 14.95€ | 14.55€ | -2.68% |
| Dassault Systèmes Se | 18.81€ | 19.72€ | 4.84% |
| L'air liquide s.a. | 161.89€ | 166.73€ | 2.99% |
The Ipsen S.A. stock price gained 0.513% on the last trading day (Friday, 29th May 2026), rising from 155.80€ to 156.60€. During the last trading day the stock fluctuated 1.81% from a day low at 154.60€ to a day high of 157.40€. The price has been going up and down for this period, and there has been a -5.66% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 412 thousand more shares were traded than the day before. In total, 548 thousand shares were bought and sold for approximately 85.81€ million.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
About Ipsen S.A.:
Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, gastroenterology, cognitive disorders, and rare diseases. It offers Somatuline for neuroendocrine tumors and acromegaly; Decapeptyl for the treatment of advanced metastatic prostate cancer; Cabometyx for renal cell and second-line hepatocellular carcinoma; Onivyde for second-line metastatic pancreatic cancer; Dysport for motor muscular disorders and medical aesthetics; NutropinAq for growth failure in children due to growth hormone (GH) deficiency, turner syndrome, chronic renal failure, and GH deficiency in adults; and Increlex for growth failure in children and adolescents. The company also offers Smecta for chronic and acute diarrhea, and pain associated with functional bowel diseases; Forlax for constipation; Fortrans/Eziclen for bowel cleansing prior to endoscopy, X-ray examination, and colonic surgery; and Tanakan for cognitive disorders in adults, vertigo of vestibular origin and vestibular rehabilitation, and tinnitus. In addition, it provides Xermelo for the carcinoid syndrome; Cometriq for medullary thyroid cancer; Smebiocta/SmectaFlora Protect, a food supplement; SmectaGas, a medical device used in the symptomatic treatment of gas-related gastrointestinal disorders and relief of gas-related symptoms; and Etiasa for inflammatory bowel diseases. Further, the company offers other consumer healthcare products in the gastro-intestinal area, including Buscopan, Clin4000, Prontalgine, Suppositoria Glycerini, Mucothiol, Floractin, and Mucodyne. Ipsen S.A. has agreements with Debiopharm; Exelixis; Galderma; Blueprint Medicines; TerSera Therapeutics; Rhythm Pharmaceuticals; Teijin; Braintree Laboratories; Ethypharm; Schwabe; BAKX Therapeutics Inc.; and Exicure. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France.
The Technip Energies N.v. stock price gained 1.55% on the last trading day (Friday, 29th May 2026), rising from 34.92€ to 35.46€. During the last trading day the stock fluctuated 3.69% from a day low at 34.68€ to a day high of 35.96€. The price has been going up and down for this period, and there has been a -4.37% loss for the last 2 weeks. Volume fell on the last day by -52 thousand shares and in total, 544 thousand shares were bought and sold for approximately 19.29€ million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Technip Energies N.v. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
The COFACE SA stock price gained 0.201% on the last trading day (Friday, 29th May 2026), rising from 14.92€ to 14.95€. During the last trading day the stock fluctuated 1.35% from a day low at 14.79€ to a day high of 14.99€. The price has fallen in 6 of the last 10 days and is down by -9.5% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 359 thousand more shares were traded than the day before. In total, 591 thousand shares were bought and sold for approximately 8.84€ million.
COFACE SA holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
About COFACE SA:
COFACE SA, through its subsidiaries, provides credit insurance products and related services for microenterprises, small and medium enterprises, mid-market companies, international corporations, financial institutions, and clients of distribution partners. The company offers credit insurance products to protect companies against default on payment of its trade receivables. It also provides integrated credit management solutions comprising credit insurance, single risk insurance, business information and debt collection services for insured and uninsured businesses; and factoring services, as well as contract and environmental surety, customs and excise, and legal bonds; and payment guarantees. In addition, the company offers business information services through its ICON portal. It operates in Western Europe, Northern Europe, Central and Eastern Europe, the Mediterranean and Africa, North America, Latin America, and the Asia-Pacific. The company was founded in 1946 and is headquartered in Bois-Colombes, France.
The Dassault Systèmes SE stock price gained 0.83% on the last trading day (Friday, 29th May 2026), rising from 18.65€ to 18.81€. During the last trading day the stock fluctuated 2.46% from a day low at 18.47€ to a day high of 18.92€. The price has fallen in 6 of the last 10 days and is down by -5.6% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 4 million more shares were traded than the day before. In total, 10 million shares were bought and sold for approximately 187.38€ million.
The Dassault Systèmes SE stock holds several negative signals and despite the positive trend, we believe Dassault Systèmes SE will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
About Dassault Systèmes SE:
Dassault Systèmes SE provides software solutions and services worldwide. It offers SOLIDWORKS design software for 3D design, electrical and printed circuit board design, product data management, simulation, manufacturing, and technical communication; CATIA, an engineering and design software for product 3D computer-aided design; GEOVIA for modeling and simulating the earth; and BIOVIA that provides the scientific community with advanced biological, chemical, and materials experiences. The company also provides SIMULIA that delivers realistic simulation applications; DELMIA, which enables global industrial operations; 3DVIA that provides 3D space planning solutions; and ENOVIA that enables to plan and track the definition of success for customer. In addition, it offers Centric PLM, a product lifecycle management software solution; 3DEXCITE, a real-time 3D visualization software; NETVIBES, which enables organizations to gather, align, and enrich big data; 3DEXPERIENCE platform that provides organizations a holistic and real-time view of their business activities and ecosystem, as well as connecting people, ideas, data, and solutions together in a single environment; and MEDIDATA, a clinical research study software that provides evidences and insights to pharmaceutical, biotech, medical device, and diagnostic companies, as well as academic researchers. Further, the company provides consulting, deployment, outcome based, and training services. It primarily serves companies in the transportation and mobility; industrial equipment; aerospace and defense; high-tech; life sciences and healthcare; energy and materials; home and lifestyle; construction, cities, and territories; consumer packaged goods and retail; marine and offshore; and business services sectors through distributors and resellers. Dassault Systèmes SE was incorporated in 1981 and is headquartered in Vélizy-Villacoublay, France.
The L'Air Liquide S.A. stock price fell by -2.15% on the last day (Friday, 29th May 2026) from 165.45€ to 161.89€. During the last trading day the stock fluctuated 2.76% from a day low at 161.89€ to a day high of 166.36€. The price has been going up and down for this period, and there has been a 1.04% gain for the last 2 weeks. Volume has increased on the last day by 2 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 3 million shares were bought and sold for approximately 416.99€ million.
The L'Air Liquide S.A. stock holds several negative signals and despite the positive trend, we believe L'Air Liquide S.A. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
About L'Air Liquide S.A.:
L'Air Liquide S.A. provides gases, technologies, and services for the industrial and health sectors in Europe, the Americas, the Asia Pacific, the Middle East, and Africa. The company's Gas & Services segment offers oxygen, nitrogen, argon, hydrogen, and carbon monoxide to the metals, chemicals, refining, and energy sectors; and gases, application equipment, and associated services to the materials and energy, automotive and manufacturing, food and pharmaceuticals, technology and research, and craftsmen and retail sectors. It also supplies medical gases, hygiene products, equipment, and services to hospitals, as well as to patients in their homes; and produces and distributes healthcare specialty ingredients for the cosmetics, pharmaceutical, and vaccine markets. In addition, this segment supplies gases, materials, and services for use in the production of semi-conductors, as well as flat screens and photovoltaic panels. Its Engineering & Construction segment designs, develops, and builds industrial gas production plants for third parties; and designs and manufactures plants in the traditional, renewable, and alternative energy sectors. The company's Global Markets & Technologies segment delivers technological solutions, such as molecules, equipment, and services to support the markets of energy transition, primarily in transport, energy, and waste valorization, as well as related to deep tech in the space exploration, aerospace, and big science. This segment also invests in biomethane production units, as well as develops stations for distributing natural bio-gas for vehicles and hydrogen to support clean mobility; operates biomethane production units for use in the maritime industry; and supplies gases for the offshore oil and gas platforms, offshore wind turbines, and cryogenic transportation by sea. L'Air Liquide S.A. was incorporated in 1902 and is headquartered in Paris, France.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
GOLDEN STAR
| Ticker | Change | Signal Date |
|---|---|---|
IDYA
$28.98
|
18.12% | Jun 12 |
DHI
$146.71
|
6.39% | Jun 10 |
|
E
ETD
$20.67
|
4.79% | Jun 05 |
EAT
$140.46
|
16.94% | Jun 05 |
TPR
$140.47
|
7.16% | Jun 04 |
